VxP Biologics Inc. provides comprehensive contract development and cGMP manufacturing of biologics at its US-FDA audited facilities in the United States as well as at its US-FDA audited cGMP facility in India.
Service areas include biologics process development and manufacturing recombinant DNA engineering cell line development protein sciences (purification and crystallography) in-vivo pharmacology and toxicology as well as cGMP antibody generation. All VxP facilities are US-FDA audited and are currently serving the global pharmaceutical and biotech industry.
VxP Pharma was founded in 2010 as CRO Solutions Inc. a sales representation agency representing global Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) from a business development and marketing standpoint. VxP Pharma was launched in 2014 as a platform to promote the combined services of all CRO Solutions clients under a single brand. VxP offers its services to research and development scientists at pharma and biotech companies worldwide and has a staff of full-time business development representatives covering all major markets as well as inside sales technical support internet marketing and operations support.
VxP Pharma CEO Raymond E Peck says “The VxP Pharma platform has been extremely successful both for us and for our global clients. Biologics has become a growing part of our portfolio so we feel that the creation of VxP Biologics is a natural extension of our service offering and of our VxP brand.”
VxP is headquartered in Indianapolis Indiana. To find out more please visit: http://www.vxpbiologics.com.